Skip to Main Content

Paper Details

Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials.
Cardiovasc Drugs Ther
12
2024

Datasets

Release 1.2